🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
60 Servings
Non-Nutrient/Non-Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Berbevis
275 mg

Other Ingredients

Rice Husk Rice Bran Extract Cellulose Water

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (86% of products) Nutrient (4% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) No Allergies Dairy Free

Product Information

📋 Directions for Use

Recommended use: 1 capsule before meals with a glass of water, twice a day.

⚠️ Warnings & Precautions

Consult with a physician prior to use if you are pregnant or nursing, taking medications or have a medical condition.

Caution: This product is not intended for individuals with impaired glucose metabolism such as prediabetes or diabetes. Do not use if safety seal is broken or missing.

Please keep out of reach of children

🧪 Formulation Notes

For healthy blood sugar metabolism

Vegan Dietary Supplement

Ultra absorption phytosome technology

The human body has difficulty absorbing berberine to unlock its true benefits. Berbevis phytosome solves this problem, boosting bioavailability 9.6x compared to standard raw extracts. This unlocks greater potency at a lower dose, allowing for a small, easy-to-swallow capsule. 9.6x better bioavailability than standard berberine

Contains no: Milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soybeans, sesame, or artificial colors and flavors. No fillers added

Made in USA with global ingredients

Additional Information

Keep closed in dry place; avoid excessive heat.

A pharmacokinetic study shows Berbevis improved berberine bioavailability (AUC) by ~ 10 times on a molar basis and with observed dose linearity.

Product Details

DSLD Entry Date 2025-05-21
Product Type Non-Nutrient/Non-Botanical
Form Capsule
Brand Enzymedica
DSLD ID 328874
Data Updated 2026-04-11

Research Evidence

98 Research Sources
55 Avg Quality Score
48 Systematic Review
39 Meta Analysis
4 Rct
4 Clinical Trial
1 Other
1 Narrative Review
1 Openfda Safety
B Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2018
B Effects berberine-silymarin on liver enzymes: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Clinical nutrition ESPEN 2022
B Efficacy and safety of berberine for several cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2023
B Effect of Berberine on C-reactive protein: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Complementary therapies in medicine 2019
B Overall and Sex-Specific Effect of Berberine on Glycemic and Insulin-Related Traits: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta Analysis The Journal of nutrition 2023
B The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review
Meta Analysis Journal of translational medicine 2024
B Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature
Systematic Review International journal of molecular sciences 2024
B Efficacy and Safety of Berberine Alone or Combined with Statins for the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis The American journal of Chinese medicine 2019
B Effects of Berries, Phytochemicals, and Probiotics on Atherosclerosis through Gut Microbiota Modification: A Meta-Analysis of Animal Studies
Meta Analysis International journal of molecular sciences 2023
B Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial
Rct JAMA network open 2025
View all evidence for Berberine →

Compare Similar Products

View all Berberine products →